| Current Price | $17.36 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $17.30 | P/E Ratio | 8.54 |
| Prev. Close | $17.15 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $17.17 - $17.53 | Volume | 3,189,564 |
| 52-Wk Range | $15.02 - $25.31 | Avg. Daily Vol. | 2,851,808 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
| Current Price | $17.36 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $17.30 | P/E Ratio | 8.54 |
| Prev. Close | $17.15 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $17.17 - $17.53 | Volume | 3,189,564 |
| 52-Wk Range | $15.02 - $25.31 | Avg. Daily Vol. | 2,851,808 |
The best Bull and Bear pitches based on recency and number of recommendations.
I often eschew Biotech at this point in history because the investments hinge on single do or die events like FDA approval. It reminds me of a Red OR Black bet on a craps table. That being said Exelixis caught my attention due to its partnerships… More
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
poluh2k
(48.48)
Submitted: 11/8/2019 4:56:06 AM :
Start Price:
$15.28
NASDAQ:EXEL Score:
+11.32
Very good data
Recs
genedom
(91.22)
Submitted: 4/24/2019 2:58:54 PM :
Start Price:
$20.73
NASDAQ:EXEL Score:
-23.79
potential buyout target. If that happens, the target price could be 30-33. Without buyout, there might be a pushup around June for the ASCO meeting.
Recs
SpartanMAC
(< 20)
Submitted: 11/12/2018 7:28:55 AM :
Start Price:
$16.57
NASDAQ:EXEL Score:
-8.82
EBITD/EV is calculated at 8%. Matched on HMG screen. Estimated future value calculated at 233 (future growth rate estimate of 46% :0).
Find the members with the highest scoring picks in EXEL.
beave35 (91.54) Score: +1,183.90
The Score Leader is the player with the highest score across all their picks in EXEL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Playa14 | < 20 |
|
|
5Y | $1.27 | +1,266.93% | +51.14% | +1,215.78 | 0 Comment | |
| beave35 | 91.54 | 12/23/2014 |
|
5Y | $1.30 | +1,235.28% | +51.38% | +1,183.90 | 0 Comment | |
| tomkao | < 20 | 12/15/2014 |
|
5Y | $1.40 | +1,140.00% | +56.19% | +1,083.81 | 0 Comment | |
| jack0071 | 71.89 | 12/3/2014 |
|
5Y | $1.43 | +1,113.99% | +51.88% | +1,062.10 | 0 Comment | |
| portefeuille | 98.38 | 12/15/2014 |
|
5Y | $1.44 | +1,105.56% | +55.88% | +1,049.67 | 0 Comment | |
| akoniec | 40.25 | 10/9/2014 |
|
3Y | $1.55 | +1,020.00% | +60.37% | +959.63 | 0 Comment | |
| dcoyne13 | 30.01 | 9/16/2014 |
|
5Y | $1.62 | +971.54% | +57.50% | +914.04 | 0 Comment | |
| foolerhoff | 92.38 | 1/6/2015 |
|
5Y | $1.64 | +958.54% | +55.80% | +902.74 | 0 Comment | |
| new2fool23 | 21.74 | 1/5/2015 |
|
1Y | $1.67 | +939.52% | +54.21% | +885.31 | 0 Comment | |
| garisonmp3z | < 20 | 1/5/2015 |
|
5Y | $1.67 | +939.52% | +54.21% | +885.31 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
